Alambic Investment Management’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-5,311
Closed -$313K 351
2019
Q1
$313K Sell
5,311
-18,597
-78% -$1.11M 0.13% 221
2018
Q4
$1.26M Buy
23,908
+8,800
+58% +$483K 0.53% 64
2018
Q3
$905K Sell
15,108
-20,574
-58% -$1.13M 0.72% 33
2018
Q2
$1.53M Sell
35,682
-22,350
-39% -$903K 0.42% 83
2018
Q1
$2.03M Sell
58,032
-46,693
-45% -$1.71M 0.28% 130
2017
Q4
$3.8M Sell
104,725
-23,048
-18% -$808K 0.46% 68
2017
Q3
$4.08M Buy
127,773
+12,915
+11% +$395K 0.45% 70
2017
Q2
$3.33M Buy
114,858
+86,458
+304% +$2.43M 0.41% 66
2017
Q1
$848K Buy
+28,400
New +$917K 0.1% 299

Other funds holding MEDP

Alambic Investment Management's MEDP Position: Q2 2019 in Review

Alambic Investment Management sold out of Medpace (MEDP) in Q2 2019, closing a stake of 5,311 shares — an estimated $313K sold.

Alambic Investment Management first reported a position in MEDP in Q1 2017 and held it in 9 quarters. The position peaked at $4.08M in Q3 2017. 225 funds tracked by Wall St. Rank hold MEDP as of Q2 2019.

  • Alambic Investment Management reported no remaining Medpace position as of Q2 2019 after selling out during the quarter.
  • Alambic Investment Management sold 5,311 Medpace shares in Q2 2019, an estimated $313K.
  • Alambic Investment Management first reported a position in Medpace in Q1 2017 and held it in 9 quarters.
  • Alambic Investment Management's Medpace position peaked at $4.08M in Q3 2017.
  • 225 funds tracked by Wall St. Rank held Medpace as of Q2 2019.

Based on Alambic Investment Management's 13F filing for Q2 2019, filed 13 Aug 2019.